TrialLancet (London, England)2015

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Eric J Lenze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.